GGrantIndex
Sort

50,496 grants matching lung cancer

Implications of metabolic heterogeneity on collective lung cancer cell invasion

$419,268
Malathy (mala) Shanmugam · Emory University · R01 · FY2024 · CA

Mates in Motion: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention

$419,253
Shelby Langer · Arizona State University-Tempe Campus · R21 · FY2023 · CA

Development of a first-in-class mEGFR dimerization inhibitor

$419,222
Mukesh K. Nyati · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Development of a first-in-class mEGFR dimerization inhibitor

$419,222
Mukesh K. Nyati · University Of Michigan At Ann Arbor · R01 · FY2020 · CA

Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites

$419,207
Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · R01 · FY2022 · CA

Arsenic Exposure and Birth Outcomes in Bangladesh

$419,202
David C Christiani · Harvard School Of Public Health · R01 · FY2010 · ES

Role of IKK alpha in lymphoid organ development

$419,198
Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Role of the SWI/SNF complex in tumor suppression

$419,188
Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2018 · CA

Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE

$419,114
Aasthaa Bansal · University Of Washington · R37 · FY2022 · CA

New approaches to local translation: spaceSTAMP of proteins synthesized in axons

$419,095
Rosalind A Segal · Dana-Farber Cancer Inst · R01 · FY2012 · MH

Topology-based tumor analysis for medical images

$419,076
Chul Moon · Southern Methodist University · R15 · FY2023 · CA

Growth Factors and Smooth Muscle Cell Lineage During Lung Organogenesis

$419,050
Saverio Bellusci · Children'S Hospital Of Los Angeles · R01 · FY2009 · HL

Targeting TREM2 to boost anti-cancer therapy

$419,032
Marco Colonna · Washington University · R01 · FY2024 · CA

Development of 3D Alveolar Tissue Models, CRISPR-editing and Microbiota-immune Response Assay Platforms for Deciphering Human Lung Immunity

$419,002
Derya Unutmaz · Jackson Laboratory · U19 · FY2022 · AI

Skeletal Muscle Atrophy and Dysfunction in Human Cancer

$418,961
Michael J Toth · University Of Vermont & St Agric College · R01 · FY2016 · AR

Breast, Colorectal, and Ovary Cancer Clinical Validation Center

$418,953
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA

Role of PTPRT in colon cancer progression and metastasis

$418,930
Zhenghe Wang · Case Western Reserve University · R01 · FY2024 · CA

Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers

$418,876
Robert Gross · University Of Pennsylvania · R01 · FY2022 · HL

Aberrant megakaryopoiesis in the myeloproliferative neoplasms.

$418,851
John D Crispino · Northwestern University At Chicago · R01 · FY2020 · HL

ISG15 and Protein ISGylation in Cancer

$418,800
Dong-Er Zhang · University Of California, San Diego · R01 · FY2019 · CA

Elucidating genetics of response to immune checkpoint blockade in lung cancer

$418,751
Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA

Genetic Modifiers of Radiation Therapy-Induced Cardiotoxicity

$418,721
Carmen Bergom · Medical College Of Wisconsin · R01 · FY2019 · HL

Therapeutic Targeting of Breast Cancer Tumor Initiating Cells

$418,717
Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

RET Regulation and Targeting in Neuroendocrine Prostate Cancer

$418,696
Justin Michael Drake · University Of Minnesota · R01 · FY2024 · CA

Systematic characterization of cancer variants using single-cell functional genomics

$418,693
Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2024 · CA